Abstract
Aim
Intraperitoneal glucose tolerance (ipGTT) and insulin challenge (ICT) tests were implemented to evaluate whether a specific glycoprotein extract of maitake mushroom (Grifola frondosa) known as SX-fraction enhances insulin sensitivity in spontaneously hypertensive rats (SHR).
Methods
SHR were divided randomly into a control group, a group receiving the antidiabetic drug, pioglitazone, in their diet, and three groups consuming three different concentrations of SX-Fraction derived from maitake mushroom in their food. The response of circulating glucose and insulin concentrations was examined at different time periods during an ipGTT. The major action of exogenous insulin during the ipGTT occurred within a 15-min period following injection of regular insulin. Accordingly, hypoglycemic activity was evaluated in SHR with and without glucose challenge over a short time frame in the ICT.
Results
Evidence gathered from the ipGTT and ICT tests suggests that the SX-fraction of Maitake in a proper dosage as well as pioglitazone enhance insulin sensitivity. Ingestion of SX-fraction produced a lower-circulating level of glucose after challenge despite no rise in circulating insulin. Compared to control, significantly lower-circulating glucose levels were seen in the groups consuming pioglitazone and higher doses of SX-fraction at 7.5 min after insulin challenge whether or not glucose was given concomitantly.
Conclusion
SHR in the pioglitazone and SX-fraction groups showed improved glucose tolerance despite no elevation of circulating insulin concentrations and showed enhanced sensitivity to exogenous insulin. Thus, a glycoprotein extract from Maitake mushroom (SX-fraction) should be considered as an alternative method for improving insulin sensitivity.
Similar content being viewed by others
Notes
Patented by Maitake Products, Inc, East Rutherford, NJ.
References
Preuss HG (1997) Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr 16:397–403
Preuss HG, Bagchi D, Clouatre D (2001) Insulin resistance; a factor in aging. In: Ghen MJ, Corso N, Joiner-Bey H, Klatz R, Dratz A (eds) The advanced guide to longevity medicine. Ghen, Landrum, SC, pp 239–250
Preuss HG, Bagchi D (2002) Nutritional therapy of impaired glucose tolerance and diabetes mellitus. In: Felix B (ed) Nutritional aspects and clinical management of chronic disorders and diseases. CRC Press, Boca Raton FL, pp 69–91
McCay C, Crowell M, Maynard L (1935) The effect of retarded growth upon the length of life and upon ultimate body size. J Nutr 10:63–79
Yu BP, Masoro EJ, Murata I, Bertrand HA, Lynd FT (1982) Lifespan study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass, and disease. J Gerontol 37:130–141
Hopkin K (1995) Aging in focus. Caloric restriction may put the brakes on aging. J NIH Res 7:47–50
Roth GS, Ingram DK, Lane MA (2001) Caloric restriction in primates and relevance to humans. Ann NY Acad Sci 928:305–315
Masoro EJ, McCarter RJM, Katz MS, McMahan CA (1992) Dietary restriction alters characteristics of glucose fuel use. J Gerontol 47:B202–B208
Preuss HG (1998) Aging: relationship to insulin resistance. Maturity: Canada 1:12–14
Dilman VM, Anisimov VN (1980) Effect of treatment with phenformin, dyphenylhydantoin, or L-DOPA on lifespan and tumor incidence in C3H/Sn mice. Gerontology 26:241–245
Preuss HG, Montamarry S, Echard B, Scheckenbach R, Bagchi D (2001) Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats. Mol Cell Biochem 223:95–102
Preuss HG, Bagchi D, Bagchi M (2002) Protective effect of a novel niacin-bound chromium complex, a grape seed proanthocyanidin extract on advancing age and various aspects of syndrome X. In: Das DK, Ursini F (eds) Alcohol and wine in health and disease. Annals NY Acad Sci 957:250–259
Talpur N, Echard B, Yasmin D, Bagchi D, Preuss HG (2003) Effects of niacin-bound chromium, maitake mushroom fraction SX and a novel (-)-hydroxycitric acid extract on the metabolic syndrome in aged diabetic Zucker Fatty Rats. Molec Cell Biochem 252:369–377
Anisimov VN, Semenchenko AV, Yashin AI (2003) Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology 4:297–307
Lane MA, Ingram DK, Roth GS (2002) The serious search for an anti-aging pill. Sci Am 287:36–41
Ingram DK, Anson RM, de Cabo R, Mamczarz J, Zhu M, Mattison J, Lane MA, Roth GS (2004) Development of calorie restriction mimetics as a prolongevity strategy. Ann NY Acad Sci 1019:412–423
Roth GS, Lane MA, Ingram DK (2005) Caloric restriction mimetics: the next phase. Ann NY Acad Sci 1057:365–371
Campbell IW (1985) Metformin and the sulphonylureas: the comparative risk. Horm Metab Res Suppl. 15:105–111
Gale EA (2001) Lessons from the glitazones: a story of drug development. Lancet 357:1870–1875
Isley WL (2003) Hepatotoxicity of thiazolidinediones. Expert Opin Drug Saf 2:581–586
Mallick S (2004) Metformin induced acute pancreatitis precipitated by renal failure. Postgrad Med J 80:239–240
Spiller HA, Sawyer TS (2006) Toxicology of oral antidiabetic medications. Am J Health Syst Pharm 63:929–938
Masubuchi Y (2006) Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review. Drug Metab Pharmacokinet 21:347–356
Langenfeld MR, Forst T, Hohberg C (2005) Pioglitazone decreases carotid intima-media thickness independent of glycemic control in patients with type 2 diabetes mellitus. Circulation 111:2525–2531
Jiang G, Zhang BB (2005) Modulation of insulin signaling by insulin sensitizers. Biochem Soc Trans 33:358–361
Lawrence JM, Reckless JB (2000) Pioglitazone. Int J Clin Pract 54:614–618
Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 50:219–244
Bunag RD (1973) Validation in awake rats of a tail-cuff method measuring systolic pressure. J Appl Physiol 34:279–282
Dunnett C (1955) A multiple comparison procedure for comparing several treatments with control. J Am Statis Assoc 50:1096–1121
Preuss MB, Preuss HG (1980) Effects of sucrose on the blood pressure of various strains of Wistar rats. Lab Invest 43:101–107
Chang S-L, Lin K-J, Lin R-T, Hung P-H, Lin J-G, Cheng J-T (2006) Enhanced insulin sensitivity using electroacupuncture on bilateral Zusanli acupoints (ST 36) in rats. Life Sci 79:967–971
Williams CA, Shih MF, Taberner PV (2000) Effect of acute and sub-chronic administration of the imidazoline compound S 22068 on in vivo glucose and insulin responses in normal lean CBA/Ca mice. Gen Pharmacol 34:183–191
Williams CA, Shih MF, Taberner PV (1999) A simple acute in vivo comparative test for sensitivity to insulin in the mouse. Horm Metab Res 31:580–582
Kim DS, Kim TW, Kang JS (2004) Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J Trace Elem Med Biol 17:243–247
Reaven GM, Hoffman BB (1987) A role for insulin in the aetiology and course of hypertension? Lancet ii:435–436
Preuss HG, Gondal JA, Bustos E, Bushehri N, Lieberman S, Bryden NA, Polansky MM, Anderson RA (1995) Effect of chromium and guar on sugar-induced hypertension in rats. Clin Neph 44:170–177
Preuss HG, Grojec P, Lieberman S, Anderson RA (1997) Effects of different chromium compounds on sugar-induced hypertension. Clin Nephrol 47:325–330
Preuss HG, Anderson RA, Gondal J (1998) Comparative effects of chromium, vanadium, and Gymnema Sylvestre on sugar-induced blood pressure elevations in SHR. J Amer Coll Nutr 17:116–123
Acknowledgment
This work was supported by Maitake Products, Inc., East Rutherford, NJ, 07073.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Preuss, H.G., Echard, B., Bagchi, D. et al. Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom. Mol Cell Biochem 306, 105–113 (2007). https://doi.org/10.1007/s11010-007-9559-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-007-9559-6